Article | January 22, 2025

Mid-Study Data Migrations: The Antidote To Longer Clinical Trials

Source: OpenClinica

By Ben Baumann

GettyImages-1081869198 data

Traditionally avoided due to complexity, mid-study migrations are becoming essential as trials increasingly extend beyond initial EDC system capabilities or organizational needs change. OpenClinica has developed and proven a robust process for seamless mid-study data migrations, ensuring minimal disruptions and complete data integrity. Key components of the process include rigorous testing and validation, data mapping, team coordination, and comprehensive training.

These migrations allow clinical trial teams to leverage modern EDC systems without compromising regulatory compliance or study timelines. OpenClinica’s tailored approach ensures all data transitions smoothly, reduces staff disruptions, and supports ongoing trial operations. As trial durations continue to grow, mid-study migrations are transforming from rare occurrences into a critical strategy for maintaining efficiency and data integrity in clinical research.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader